Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve unaudited financial results for ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech has informed the BSE that its Board of Directors will meet on Friday, 14 November 2025. The main agenda is to consider and approve the unaudited financial results for the quarter ended 30 September 2025 (Q2 FY26). The trading window for dealing in the company's securities is closed until close of business on 16 November 2025 and will reopen on 17 November 2025, as per the insider trading code. The intimation has been issued under Regulation 29(1) of SEBI's LODR Regulations, 2015 by Priyanka Sharma, Company Secretary & Compliance Officer.
This is a routine advance notice ahead of the Q2 results announcement on/before 14 November. Investors should watch the actual results for any surprises on revenue, profitability, or margins, as no financial numbers are disclosed in this filing.